As the festive season approaches, experts have a warning for those taking prescription GLP-1 receptor agonist drugs.

More than half a million people are buying weight-loss injections online because of the “slow” rollout of the drugs by the ...

Zepbound, which shares the same active ingredient as Lilly’s diabetes drug Mounjaro, is already approved by the FDA to treat ...

Since pharmaceutical giant Eli Lilly (NYSE: LLY) reported earnings for the third quarter on Oct. 30, shares have been ...

The federal government is phasing out off-brand copies of two blockbuster drugs used to treat obesity and diabetes.

Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration ...

Whether it’s Ozempic, one of the antidiabetic drugs that have gained popularity for its weight loss benefits, or a similar ...

The FDA has declared the end of the two-year shortages of Eli Lilly's Mounjaro and Zepbound — used to treat diabetes and weight loss, respectively — and has reaffirmed its decision to halt the ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 471.82% and ...

The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but potentially serious sleep-related breathing disorder, marking it the first ...

Investing in dividend stocks is a great strategy for many reasons, including the potential they offer you to significantly ...

The FDA declared a shortage of popular weight-loss and diabetes drugs. Here's what that means for people who get generic ...